Table 2.
Primary and Secondary Diagnostic Parameters Derived from the EMM in Malignant and Benign Lesions
| Type of Lesions | No. Cases | A | α (min−1) | β (min−1) | AUC30 | Slopeini (min−1) | Tpeak (min)* | κpeak | SER |
|---|---|---|---|---|---|---|---|---|---|
| All benign | 34 | 4.2 ± 2.2 | 1.6 ± 1.1 | 0.045 ± 0.047 | 0.55 ± 0.35 | 6.1 ± 4.6 | 3.4 ± 1.8 | 30.30 ± 0.49 | 0.88 ± 0.30 |
| FCC | 16 | 3.9 ± 1.8 | 1.3 ± 1.0 | 0.039 ± 0.046 | 0.48 ± 0.39 | 5.3 ± 5.5 | 4.0 ± 1.6 | 30.23 ± 0.56 | 0.78 ± 0.28 |
| Fibroadenoma | 4 | 6.5 ± 2.6 | 0.69 ± 0.22 | 0.050 ± 0.066 | 0.48 ± 0.25 | 4.4 ± 2.4 | 4.2 ± 1.4 | 30.22 ± 0.25 | 0.65 ± 0.19 |
| Papilloma | 7 | 3.6 ± 1.9 | 2.5 ± 1.1 | 0.050 ± 0.022 | 0.62 ± 0.28 | 7.5 ± 3.6 | 2.0 ± 1.2 | 30.33 ± 0.14 | 1.08 ± 0.7 |
| Others | 7 | 4.3 ± 2.8 | 2.0 ± 1.1 | 0.050 ± 0.063 | 0.66 ± 0.36 | 7.4 ± 4.4 | 3.2 ± 2.0 | 30.45 ± 0.64 | 1.04 ± 0.30 |
| All malignant | 79 | 4.0 ± 2.2 | 2.1 ± 1.1 | 0.058 ± 0.061 | 0.71 ± 0.54 | 8.7 ± 8.3 | 2.8 ± 1.9 | 30.67 ± 1.18 | 1.14 ± 0.48 |
| DCIS | 30 | 2.8 ± 1.9 | 1.8 ± 0.9 | 0.037 ± 0.058 | 0.40 ± 0.23 | 4.3 ± 2.6 | 3.6 ± 2.0 | 30.18 ± 0.31 | 0.96 ± 0.35 |
| IDC | 36 | 4.9 ± 2.0 | 2.6 ± 1.3 | 0.072 ± 0.062 | 1.01 ± 0.62 | 13.1 ± 10.2 | 2.0 ± 1.5 | 31.12 ± 1.57 | 1.31 ± 0.55 |
| ILC | 7 | 3.1 ± 2.1 | 1.5 ± 0.4 | 0.054 ± 0.062 | 0.44 ± 0.26 | 4.6 ± 2.7 | 3.2 ± 2.0 | 30.35 ± 0.40 | 1.04 ± 0.30 |
| Others | 6 | 5.6 ± 1.4 | 1.6 ± 0.9 | 0.087 ± 0.046 | 0.78 ± 0.38 | 8.5 ± 4.7 | 2.3 ± 1.0 | 30.82 ± 0.89 | 1.14 ± 0.57 |
Reported values are mean ± standard deviation for all cases. Numbers in bold indicate that there was a statistically significant difference between benign and malignant lesions.
*
For those curves which did not reach a peak within the duration of the experiment, we assumed a time to peak of 5 min.